StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cocrystal Pharma's price to sales ratio was 41.3× on Apr 30, 2021, against 5.0× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 202141.3×−7.7
2020Dec 31, 202048.9×–

More Cocrystal Pharma figures

See a number that looks wrong?